Although the benefits of antenatal hormone treatment are well accepted, most studies have reported only pulmonary effects. There is evidence of beneficial cardiovascular and metabolic effects in studies using chronically catheterized animals; however because of the route of administration, the results are not directly applicable to clinical strategies. We previously demons trated sign ificant pulmonary effects in animals treated antenatally with a single, direct fetal, intramuscular injection of glucocorticoids . Th is study was performed to determine the effects of a single fetal injection of betamethasone (BETA) alone or in combination with thyroxine (T 4 ) on cardiovascular and metabolic respons es after preterm birth . Hemodynamic and metabolic response s at birth were determined in fetuses (126-d gestation; term = 150 d) treated with ultrasound-guided intramuscular injections of 0.5 mg/kg BETA (n = 7), BETA plus 60 g/kg T 4 (n = 7), or saline (SAL, n = 9). After 48 h, lambs were delivered by cesarean section and studied for 3 h. BETA treatment increased mean arterial blood pressure [56 ± 6 (SEM) versus 42 ± 3 mm Hg], heart rate (152 ± 5 versus 123 ± 4 beats/min), and cardiac Multiple studies have documented improved outcomes of preterm human infants born to mothers treated antenatally with glucocor ticoids. Most studies have focused primarily on pulmonary effects, although secondary outcome variables and retrospective metanalysis of clinical and other demographic data indicate beneficial effects in other organ systems (1, 2). Maternal corticosteroid treatment reduces nonrespiratory morbidities such as intraventricular hemorrhage, necrotizing enterocolitis, and patent ductus arteriosus. The mechanism(s) for these varied clinical outcomes is uncertain .
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In previous studies using chronically catheterized fetal sheep we demonstrated that antenatal corticosteroid infusion signifi-outpu t (467 ± 17 versus 349 ± 36 mlzmin/kg) versus SAL.
Responses of BETA + T 4 -treated animals were not different from animals treated with BETA alone. Glucose and FFA were simila r among all groups. The increase in catecholamine levels normally seen at birth was significantly attenuated in both the BETA and BETA + T 4 -treated animal s. A single, intramuscular injec tion of glucocorticoids 48 h before delive ry improves cardiovascular responses to preterm birth . This effect is not augmented by concomitant admi nistration of T4 ' (Pediatr Res 38: 709-715, 1995) Abbrev iations BETA, betamethasone T 4 , thyroxine T 3 , triiodothyronine SAL , saline TRH, thyrotropin-releasing hormone ANOVA, analysis of variance dP/dt, change in pressure per unit time cantly improved cardiovasc ular responses at birth, as illustrated by increases in blood pressure, left ventricular contractility, and cardiac output (3). Infusion of both corticosteroids and TRH resulted in even greater improvement in postnatal blood pressure when compared with animals treated with corticos teroids alone or when compared with controls (4) . Although these studies demonstrated significant effects, the use of chronically catheter ized animals for drug administratio n is not directly applicable to development of treatment regimens which may be suited to clinical use. Catheterized animals generally receive continuous or multiple hormone treatments, and the effects of fetal surgery may alter the response of the fetus to hormone treatment (5) . Recently, a single direct fetal injection of corticosteroids alone or in combination with thyroid hormones has been shown to improve ventil atory function in noncatheterized, prematurely delivered sheep (6) (7) (8) . The direct fetal route of administration is attractive because, given 70Q the quality of imaging techniques clinically available, it is technically feasible to accomplish direct injection in the human as well. Before initiation of such treatments, however, it is necessary to fully evaluate the multiorgan system effects relative to studies using chronically catheterized models. Thus, our objective was to assess the effects of direct fetal hormone administration on postnatal cardiovascular and metabolic function. We evaluated BETA because of its demonstrated effects on pulmonary maturation. Thyroid hormones do not cross the placenta, so if the fetus is to benefit from the addition of thyroid hormone to antenatal glucocorticoids, it must either be given by intraamniotic injection, by fetal intramuscular injection, or indirectly by maternal administration of TRH. Maternal TRH administration induces only a modest effect on fetal thyroid levels. To evaluate the ability of thyroid hormone to augment the effects of glucocorticoids, we evaluated the effects of BETA alone and in combination with a near maximal dose of 1'4' We compared our results with those previously reported in chronically catheterized animals.
METHODS
Animal model and delivery protocol. Pregnant ewes with singleton fetuses were obtained from our local supplier (Nebeker Ranch, Palmdale, CA). At 126-d gestation (term = 150 d) ewes were restrained without anesthesia for ultrasound imaging of the fetus (6) (7) (8) . Using a real time ultrasound system (Ausonics) with a 5 MHz sector transducer, the fetal heart and chest were imaged and, using a 9-cm 20 gauge spinal needle, the fetus was injected in the shoulder with either SAL, 0.5 mg/kg BETA (Celestone Soluspan, Schering Pharmaceuticals) alone, or BETA plus 60 p,glkg T4 (BETA + T4)' A body weight of 3 kg was used to estimate hormone doses in an injection volume of 2.5 mL of SAL.
At 128-d gestation, 48 h after fetal injection, the ewes were sedated with ketamine (15-20 mg/kg, intramuscularly) and given combined spinal-epidural anesthesia (10 mL of 2% lidocaine:0.5% bupivacaine, 1:1). The head and neck of the fetus were delivered through a midline abdominal incision and hysterotomy as described previously (3, 4, 9) . Fetuses received an intr amuscular injection of ketamine (10 mg/kg) and acepromazine (0.1 mglkg). The anterior neck was infiltrated with 2% lidocaine, followed by tracheotomy and insertion of a 4.5-mm endotracheal tube. Lambs were delivered, dried, weighed, and treated with 100 mg/kg surfactant (Survanta®, provided by Ross Laboratories, Columbus, OH) via direct intratracheal instillation before the first breath. Lambs were mechanically ventilated with a time-cycled, pressure-limited infant ventilator set to deliver 100% Oz. Initial ventilator settings included a positive-end expiratory pressure of 3 em HzO, a rate of 40 breaths/min, and an inspiratory time of 0.7 s. Peak inspiratory pressure was initially set at 35 em HzO and adjusted to achieve arterial Pee, values of 4-5.5 kPa. Peak inspiratory pressure was limited to 40 em HzO to avoid pneumothorax.
The investigators delivering and managing the preterm lambs were blinded as to treatment group. All newborn lambs were managed as described previously in delivery protocols of chronically catheterized fetuses (3, 4, 9) . Procedures included: insertion of an umbilical artery catheter for blood sampling and blood gas monitoring; administration of 10 mL/kg heparinized placental blood within 5 min of delivery to all animals; insertion of a left ventricular catheter via the right carotid artery during continuous measurement of left ventricular pressure, left ventricular dP/dt and the injection of microspheres; administration of 5% dextrose in water into the umbilical artery and left ventricular catheters at a total rate of 4.5 mLlkg/h throughout the study protocol. A suprapubic cystostomy catheter was also inserted within 10 min of delivery for continuous collection of urine. Local anesthesia was given before all procedures were carried out. The data describing effects on renal (10) and pulmonary function (7) are the subject of other reports. Total administered fluid volume, blood pressure and heart rate were monitored continuously.
Arterial blood samples (0.3 mL) for measurements of pH and blood gasses were obtained every 30 min, and/or 5 min after ventilator adjustments to permit careful monitoring of ventilatory status. Blood samples (6 mL) were collected from the umbilical cord after delivery of the lamb, and from the umbilical artery catheter at 20, 60, 120, and 180 min after delivery for measurements of catecholamines, glucose, FFA, 1'4' and cortisol. Blood samples were replaced with an equal volume of washed, filtered maternal red blood cells. Body temperature was monitored continuously by rectal thermistor and maintained at 39 :±: 1°C using a radiant warmer, heating pad, and heat lamps. Evaluation of postnatal adaptation continued until 3 h after birth, after which time the lambs were killed with an overdose of pentobarbital (100 mg/kg).
Cardiac output was measured at 30 and 180 min after birth using radiolabeled microspheres (10) . Either 57CO_ or 43Sr_ labeled microspheres of known total radioactivity (DuPont NEN, Boston, MA) were mixed with 5 mL of maternal blood just before being injected over 15 s into the left ventricle. A reference sample was simultaneously withdrawn with a Harvard pump (Harvard Apparatus Co., South Natick, MA) from the descending aortic catheter at a rate of 5 mlzmin for 2 min into a preweighed, heparinized syringe. The blood volume was determined by weight, and then radioactivity was quantified in a LKB Compugamma counter equipped with automatic pulse height correction.
Analytical techniques. Blood samples were placed immediately into chilled test tubes for determination of cortisol and 1'4 (lithium heparin; 40 p,g/mL blood) as well as catecholamines , glucose, and FFA (4 mM EGTA and 3 mM reduced glutathione/mL blood). Tubes were mixed and centrifuged immediately at 4°C. Plasma samples were separated and frozen (-20°C) for extraction within 1-2 wk. Plasma 1'3 and 1'4 levels were measured with commercially available RIA kits (lCN Pharmaceuticals, Costa Mesa, CA). Plasma catecholamine levels were determined by radioenzymatic assay sensitive to 10-20 pg/mL (3, 9) . FFA were measured by a microcolorimetric assay and glucose by an automated analyzer (Yellow Springs Instrument Co., Yellow Springs, OH) as described previously (3, 9) . Blood pH, POz, and Pco; values were determined at 39°C on a Radiometer blood micro acid-base analyzer ..c Umbilical cord blood pH, blood gases, and hematocrit are shown in Table 1 . There were no significant differences among the three groups. Mean body weight and individual organ weights are shown in Table 2 . As noted in previous studies of chronically catheterized animals treated with corticosteroids, there was a significant reduction in lung weight in the steroid treated animals (3, 4) . In the present study, the lungs of both the BETA-and BETA + T 4-treated animals were significantly lighter than in animals treated with SAL alone. There were no other significant differences in organ weights among the groups.
Cardiovascular. Serial heart rate and blood pressure values are shown in Figure 1 . Heart rate was significantly higher in the BETA-treated animals than in SAL controls, p < 0.05, ANOVA. This difference was apparent by 120 min of age and persisted through 180 min. Both mean arterial pressure and left ventricular pressure were significantly higher in the BETAtreated animals than in SAL controls, P < 0.01, ANOVA. In contrast, the heart rate and blood pressure of BETA + T 4 -treated animals did not differ from the controls. Cardiac output, stroke volume, and calculated systemic vascular resistance are shown in Figure 2 . Left ventricular output was significantly higher at 30 min of life in each of the groups than values previously reported for fetal left ventricular output (11). Unexpectedly, cardiac output was less at 30 min of life in animals treated with the combination BETA + T 4 compared with animals treated with SAL alone, but not the BETA alone animals. By 180 min, the BETA-treated animals had significantly higher cardiac output than the animals treated with SAL alone, but it was not significantly greater than the animals treated with BETA + T 4 , P < 0.001. Left ventricular dP/dt and left ventricular end diastolic pressure are shown in Figure 3 . Left ventricular dP/dt and stroke volume were significantly higher in the BETA-treated animals than either of the other two 
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The present studies were carried out to assess the effects of direct fetal hormone administration on postnatal cardiovascular and metabolic function and to compare responses with those reported in chronically catheterized animals. We showed that a single fetal treatment with glucocorticoids results in significantly greater mean arterial pressure, cardiac output, and cardiac contractility than in SAL-tr eated control animals. Taken DISCUSSION SAL-tre ated lambs. By contrast in both the animals treated with BETA alone or BETA plus T 4 , the increase in levels of both catecholamines was blunted. The plasma levels of T 3 and T4 were measured in the umbilical cord samples and after birth at 30, 60, 120 and 180 min. The cord blood and levels at 120 min are shown in Table 3 . The maximum increase in T 3 occurre d at 120 min. As can be seen, the single injection of BETA was associ ated with a significant increase in T 3 concentration in cord blood and in the peak response at 120 min of life, p < 0.05. The plasma T 3 concentration at 120 min in the animals treated with BETA alone was significantly greater than that seen in the animals treated with BETA + T4' Calculated systemic vascular resistance was similar in all three groups at 180 min. Metabo lic. Plasma glucose and FFA levels after delivery are show n in Figure 4 . Blood glucose levels did not change after birth, and there were no differences among the groups. There was a modest but significan t overall increase in FFA after birth, 80 ± 5 p,M/L before delivery versus 131 ± 13 p,M/L at 180 min. However, there were no significant differences among the groups in postnatal FFA responses.
En docrine. Circulating plasma catecholamine concentrations are shown in Figure 5 . Both circulating norepin ephrine and epinephrine levels increased significantly after delivery in L----------------- 
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togeth er with earlier studies in chronically catheterized animals and the results of clinical trials (3, 4, 12, 13) , the present results add to the appreciation that significant augmentation in cardiovascul ar function at birth is also seen after fetal corticosteroid treatm ent. A number of nonpulmonary neonatal morbiditi es are reduced after maternal steroid administration. These include intraventricular hemorrhage (1, (14) (15) (16) , periventricular leukomalacia (16) , necrotizing enterocolitis (17) , and patent ductus arteriosus (12, (15) (16) (17) (18) . An important role for disordered blood pressure regulation and of hypotension in the etiology of intraventricular hemorrhage and periventricula r leukomalacia has been established in both animal models (19) and humans (16, (20) (21) (22) (23) (24) . Hem odynamic inst abilit y and hypotension, whether as a result of sepsis or asph yxia, are also important in the pathogenesis of necrotizing enterocolitis (25) . The clinical relevance of the observations in the present study may be that cortic osteroid induced improvements in cardiovascular function are involved in the reduction in incidence or severity of these compl ications in infants whose mothers received antenatal hormone treatment.
We chose to evaluate the additive effects of T 4 with BETA rather than T3 becau se preliminary studies showed a greater improv ement in lung compliance and lung volume with T 4 than T 3 when each was given in combination with corticosteroids by direct fetal injection (8) . We evaluated T 4 at a dose of 60 fLglkg functi on is not known . It is possibl e that a lower dose of T 4 would have been associated with more salutary cardiovascular effects than we obs er ved . Further studies are need ed to optimize the combination of corticosteroids, thyroid hormones, and other age nts for fetal maturation.
In adult animals hyp erth yroid ism induces cardiac hypertroph y and increased cardiac contractility (26, 27) . Th e effec ts of thyroid status on development of the cardiov asc ular system in fetal sheep is complex. Thyroidectomy of pr eterm fetal sheep significa ntly depresses the normal incr eases in blood pressure, cardiac output and oxygen consumption in animals born at term (11, 28) . T he latt er effect is due in part to imp airment of the ont ogenetic increase in myocardial f3-adrenergic receptors and f3-receptor-stimulated adenyl cycl ase (28) . Thyroidectomy results in hypotension, obtunded blood pressure, and blunted catecholamine resp on ses to induced hyp oxia in chronicall y catheterized fet al sheep (29) . The reductions in blood pres sur e and myoc ardi al performanc e at birth after fetal thyroidectomy may be secondary to structura l alterations or altered expression of myocardial isomyosin subtypes (30) . Adrenergic mechanism s are als o important in the incr ease in lung dist ensibility, lung stability, and sur factant flux seen after the combination of cortiso l and TRH (31 ) .
We evalua ted alterations in growth by me asuring body and organ weights. Studies in rats and rabbits have shown intr auterine growth retardation in corticosteroid-treated fetuses (32) (33) (34) ; similar effects have not been ob served in shee p (3, 4) or humans (1). Thi s adv erse imp act on intrauterine growth and significa ntly increased fetal mortality (34, 35) suggests that studies in sm all mammalian species are les s relevant to the responses one sees in larger animals or hum ans. Th e greater redu ction in lung we t w eight noted after treatment with corticosteroids eith er alone or in co mbination with T4 is consistent with the interpretation of enh anced lung fluid absorptio n du e to corticosteroid-induced acceleration of this response. As not ed by Barker et al. (36) , the resorption of lung fluid does not normall y occur until after 130 d of ge stati on. Resorption of fetal lun g fluid is augmented by adrenergic mechanisms, and this response ca n be induced precociously in thyroidectomized fetal lambs treated with both glucocorticoids and thyroid hormone.
One of the important metabolic adaptations to postnatal life is a bri sk increase in cir cul atin g glu cose and FFA after birth (37, 38) . Lipolysis with resultant increase in FFA and glycerol is vit al to postnatal surviva l (38) . The magnitude of this response is gr eater in mature newborn anima ls than in prematurel y delivered sheep (39) . We anticipated that antenatal hormone treatment of these preterm animals might augme nt this adaptive response (40, 41). As wa s seen for the ca rdiov ascular effects, it is po ssible that a low er dos e of T 4 may hav e augmented the FFA responses as had been anticipated. Th e results of the thyroid hormone assa ys demonstrate that anten atal BETA exp osure augments fet al umbilical and postnatal circulating T3 level s. The mechanism for this effect is presumed to be induction of the hepatic monodeiodinase activity responsible for T 4 to T 3 conversion (8, 42) . The dose of T 4 we used in combination with BETA in the present study blunted both the prenatal and postnatal increase in T 3 , presum ably via suppress ion of thyroidal T 4 secretion. Th ere w as littl e effect of the antenatal T 4 injection on umbilical cord blood T 4 concentration or postnatal levels. As noted in previous studies usin g chronically catheterized animals infused with corticosteroids alone or in combination with TRH, ant enatal exposure of the fetus to co rticosteroids is also assoc iated with a significant blunting of the usual exponential increase in circulating catecholamines (3 , 4) . Similar results were seen in the present studies where fet al hormone exposur e was achieved with a single fet al intramuscular injection. The explanation for this effect is not kno wn.
In summary, we showe d that a single, direct fetal injection of BETA improved blood pressure, cardiac contractility, and cardiac output at birth. These effects were largely inhibited wh en the animals were also treated with a large dose ofT 4 • We belie ve that some form of direct fetal treatment will be part of clinically relevant approaches to improving fetal maturation in the future. Such an approach allows the use of agents which may not reach the fetus via the placental circulation or are contraindicated maternally. The present studies demonstrate the importance of prior testing to optimize dos e and treatment combination s.
